When Renold J. Capocasale learned that he was being laid off by Johnson & Johnson, where he had worked as a research scientist for 16 years, he took swift and decisive action to transition into the next chapter of his career. Mr. Capocasale founded Doylestown, Pa.-based FlowMetric Inc. in March 2010, just months after being laid off in October 2009. FlowMetric is a niche contract research organization (CRO) that provides flow cytometry services to the biotechnology and pharmaceutical sectors. In launching FlowMetric, Mr. Capocasale drew on two decades of experience in the industry. At Johnson & Johnson’s Centocor division, he was part of the team that developed Stelara and Remicade, two drugs on the market today that are used to treat plaque psoriasis. He previously served as an associate research scientist at Medarex Inc., which was acquired by Bristol-Myers Squibb in 2009.
…………….Read the rest of the article here………….